Rapid assessment tool for Haemophilus influenzae type b disease in developing countries

Daniel R. Feikin, Christopher B. Nelson, James P. Watt, Ezzeddine Mohsni, Jay D. Wenger, Orin S. Levine

Research output: Contribution to journalArticle

Abstract

Haemophilus influenzae type b (Hib) still causes a substantial number of deaths among children in developing countries, despite the availability of effective conjugate vaccines. A major obstacle in developing a Hib vaccine has been limited awareness about the impact of Hib disease. A tool was developed to estimate the national rates of Hib meningitis and pneumonia by assessing retrospective local data over 7 to 10 days. Data from 11 countries in Africa, the Middle East, and Asia were studied and showed rates of Hib meningitis from >50 cases per 100,000 children >5 years in Ghana and Uganda to <15 per 100,000 in Iran, Jordan, and Uzbekistan. Results were affected by the quality of available data. The Hib rapid assessment tool can be useful to countries that desire a timely assessment of Hib disease rates.

Original languageEnglish (US)
Pages (from-to)1270-1276
Number of pages7
JournalEmerging infectious diseases
Volume10
Issue number7
DOIs
StatePublished - Jul 2004
Externally publishedYes

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Rapid assessment tool for Haemophilus influenzae type b disease in developing countries'. Together they form a unique fingerprint.

  • Cite this